- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 24, 2024, 04:37:48 PM
- Local Time:
- June 16, 2024, 11:08:26 PM
- Last Active:
- May 24, 2024, 07:46:38 PM
Signature:
Results from the enrollment scientific studies regarding nintedanib led to authorization in the substance to treat idiopathic lung fibrosis and chroni